
    
      Primary Objective:To determine the efficacy of the combination of LD TSEBT and mogamulizumab
      in patients with MF and SS

      Secondary Objective: To evaluate the secondary measures of clinical benefit of the
      combination therapy and to evaluate the safety and tolerability of the combination in
      patients with MF and SS
    
  